Cargando...

Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia

BACKGROUND: Vimentin (VIM) is a type III intermediate filament that maintains cell integrity, and is involved in cell migration, motility and adhesion. When overexpressed in solid cancers, vimentin drives epithelial to mesenchymal transition (EMT) and ultimately, metastasis. The effects of its overe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Transl Med
Main Authors: Wu, Sharon, Du, Yang, Beckford, John, Alachkar, Houda
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2018
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6009962/
https://ncbi.nlm.nih.gov/pubmed/29925392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1539-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!